Dr. Eric F. Bernstein

Eric F. Bernstein, MD, is a distinguished practitioner, researcher and innovator in the fields of dermatology and laser surgery. He received his BS from Duke University and MD from the Yale University School of Medicine, and an MSE in Management of Technology from the Engineering School at University of Pennsylvania, co-administered by the Wharton School.

Following fellowships with the National Cancer Institute at the National Institutes of Health and Drexel University, he joined Jefferson Medical College, where he directed a photobiology laboratory and served as the first director of the Laser Surgery Center. His research on a molecular model of skin photoaging led to the development of his own firm, DakDak LLC, which performs in vitro phototoxicology testing for large pharmaceutical companies and pursues discovery of novel anti-aging and pharmaceutical compounds.

Dr. Bernstein holds numerous U.S. and international patents, has authored over 50 peer-reviewed articles, over 25 book chapters and review articles, and has given more than 200 presentations at scientific meetings. Dr. Bernstein heads the medical advisory board for Candela Corporation, a leading manufacturer of medical laser systems, and is on the advisory board of a number of other laser companies. Dr. Bernstein is currently Chairman of the board of Freedom-2, Chairman of the board of American Medical Media, a principal in a number of start-up companies in the medical space, and he also consults with numerous cosmetic and biotechnology firms, and is on the medical advisory board of HealthCor Partners, a premier hedge fund that invests in the medical space. He currently serves as Clinical Associate Professor of Dermatology at the University of Pennsylvania and teaches a course in biotechnology and medical devices in the executive Masters of Technology Management program at Penn.